MDL Judge Will Consider New Expert Evidence That Tylenol Causes ADHD in Lawsuits Filed After Jan. 12, 2024
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
FDA Was Pressured By J&J Not to Address Tylenol Liver Damage Risk: Report September 23, 2015 Irvin Jackson Add Your Comments Documents recently described in the pending litigation over Tylenol suggest that Johnson & Johnson officials tried to leverage the FDA, Congress and even the White House through their lobbyists, in an attempt to prevent restrictions on Tylenol and other acetaminophen-based products, despite evidence that high doses may increase the risk of liver damage. The information was presented as part of a trial that began this week in the Superior Court of New Jersey, involving a liver damage lawsuit filed by Regina Jackson, who was hospitalized due to elevated liver enzymes after accidentally overdosing on Extra Strength Tylenol. The case is one of more than 200 similar Tylenol liver damage lawsuits pending in various state and federal courts nationwide, which all allege that Johnson & Johnson provided false and misleading information about the risks associated with the pain reliever acetaminophen. Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tylenol is one of the most widely used painkiller medications in the United States, which is widely assumed to be safe by most consumers and has been used by millions of Americans. The acetaminophen contained as the active pharmaceutical ingredient in Tylenol has been identified in recent years as a leading cause for liver injury in the United States. All of the complaints involved in the Tylenol litigation raise similar allegations that Johnson & Johnson knew or should have known for decades that side effects of Tylenol increase the risk of liver damage, yet failed to adequately warn consumers or the medical community. A number of documents revealed during the discovery process in the Tylenol litigation indicate that Johnson & Johnson executives were alarmed that the FDA was considering restrictions on the use of Extra Strength Tylenol, due to its links to liver damage. A recent story by the public interest journalism organization ProPublica highlights the drug maker’s attempts to avoid regulations that would restrict use of their popular brand-name pain killer, distributed by it’s McNeil Healthcare subsidiary.. One of the documents described in the report outlines how the company planned to keep the FDA from following the advice of its advisory committee, which recommended that Extra Strength Tylenol no longer be available over-the-counter. “Here is how we are going to do it. We’re going to involve key opinion leaders, and we’re going to get them to help us influence the FDA to disregard what the advisors said,” according to a PowerPoint presentation. The company lobbied Congress and even the White House in attempts to keep Extra Strength Tylenol on store shelves despite the FDA’s misgivings, according to information presented in the case. The first FDA hearings on liver damage caused by acetaminophen began 38 years ago, but the agency still has not taken action to make regulations regarding the safe use of Tylenol, Jackson’s attorneys note. Tylenol Liver Damage Concerns In a consumer update issued by the FDA on May 28, 2014, the agency warned that there is no way of determining who may experience liver damage due to a Tylenol overdose. Additionally, many consumers accidentally overdose on its active ingredient, acetaminophen, because they do not realize that it is in numerous cold medications and pain relievers. The FDA has indicated that acetaminophen may be responsible for more than 50,000 emergency room visits each year, including 25,000 hospitalizations and over 450 deaths annually. In recent years, efforts have been ramped up to bring the risk of acetaminophen overdose to the public’s attention and to reduce the amount of liver injury cases linked to the popular analgesic. In 2011, Johnson & Johnson lowered the maximum recommended dosage on Tylenol and other acetaminophen-based products from 4,000 mg per day to 3,000 mg per day, after the FDA announced the new limits on acetaminophen levels in prescription painkillers like Vicodin and Percocet. However, the drug maker continues to maintain that Tylenol is a safe and effective, and few consumers realize the risk of liver damage that may be caused by taking more than two pills with each dose or failing to carefully monitor the frequency of doses. Many of the complaints pending nationwide suggest that the FDA would never approve Tylenol as an over-the-counter medication if it were first introduced today. Tags: Acetaminophen, Johnson & Johnson, Stevens-Johnson Syndrome, Tylenol More Tylenol Lawsuit Stories MDL Judge Grants Summary Judgment in All Tylenol Lawsuits Over Autism, ADHD August 21, 2024 Tylenol MDL Judge Rejects New Evidence That Prenatal Exposure to Acetaminophen Causes ADHD July 15, 2024 MDL Judge Will Consider New Expert Evidence That Tylenol Causes ADHD in Lawsuits Filed After Jan. 12, 2024 March 22, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025) Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Tylenol MDL Judge Rejects New Evidence That Prenatal Exposure to Acetaminophen Causes ADHD July 15, 2024
MDL Judge Will Consider New Expert Evidence That Tylenol Causes ADHD in Lawsuits Filed After Jan. 12, 2024 March 22, 2024
New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)